OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
AFib is the most common type of heart arrythmia 2. Left untreated, it increases risk of stroke, heart failure, myocardial ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
Exposure to extreme heat may double or triple the risk of irregular heart rhythms in people with implanted defibrillators, ...
The article discusses the evolution and significance of ECG systems in cardiac monitoring. It highlights their role in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback